[University home]

School of Medicine

Professor Robert Hawkins MA MB BS PhD FRCP

Photograph of Robert Hawkins

Cancer Research UK Professor of Medical Oncology

School of Cancer and Imaging Sciences
Faculty of Medical & Human Sciences
University of Manchester
c/o Paterson Institute for Cancer Research
Christie Hospital NHS Trust
Wilmslow Road
Manchester
M20 4BX

 

Role

Robert Hawkins is Cancer Research UK Professor and Director of Medical Oncology at the University of Manchester and Christie Hospital. His research interests are in gene and immunotherapy. In addition to clinical training at the Royal Marsden Hospital and Addenbrookes Hospital in Cambridge he was an MRC Research Fellow with Dr Greg Winter and Dr Cesar Milstein at the MRC laboratory of Molecular Biology in Cambridge. His PhD was in antibody engineering and as a Cancer Research UK Senior Clinical Fellow he developed translational research interests in antibody based gene therapy. He was first appointed as a consultant in Medical Oncology at Addenbrooke’s Hospital in Cambridge in 1995 and then became Professor of Oncology at the University of Bristol in 1996. In 1998 he moved to the Christie Hospital to become Professor and Director of Medical Oncology. Clinically, Professor Hawkins focuses on treating renal cancer and cancer of the oesophagus/stomach. He heads a clinical research group undertaking trials in these cancers and also a range of early phase clinical trials of biological agents including vaccines, antibodies and cellular therapy. He has major grants from Cancer Research UK, the Kay Kendall Leukaemia Fund and the European Union (he is Co-ordinator of the ATTACK project; www.ATTACK-cancer.org) and has published widely in scientific and clinical journals and is an inventor / co-inventor on several antibody related patents.

 

Qualifications

  •   MB, BS(London), MA, PhD, FRCP
 

Collaborators and affiliated staff

Dr David Gilham

Dr Eyad Elkord

Dr Eleanor Cheadle

Dr Ryan Guest

Professor Peter Stern

 

Selected publications

2006

  • Jiang H, Gilham D, Mulryan K, Kirillova N, Hawkins RE, Stern PL. (2006) Combination of vaccination and chimeric receptor expressing T cells provides improved active therapy of tumors. J Immunol, 177( 7), 4288-98. further details

2004

2002

  • Armstrong A, Dermime S, Allinson C, Bhattacharyya T, Mulryan K, Gonzalez K, Stern PL, Hawkins RE. (2002) Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitope. J Immunol, 168( 8), 3983-91. further details
  • Eaton D, Gilham DE, O'Neill A, Hawkins RE. (2002) Retroviral transduction of human peripheral blood lymphocytes with Bcl-X(L) promotes in vitro lymphocyte survival in pro-apoptotic conditions. Gene Ther, 9( 8), 527-35. Full text doi:10.1038/sj.gt.3301685 further details

View all Publications

Top of page